Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Moodys
McKesson
Medtronic

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Emodepside


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Emodepside?

Emodepside is an investigational drug.

There have been 4 clinical trials for Emodepside. The most recent clinical trial was a Phase 1 trial, which was initiated on August 15th 2021.

The most common disease conditions in clinical trials are Filariasis, Hookworm Infections, and Communicable Diseases. The leading clinical trial sponsors are Bayer, Bill and Melinda Gates Foundation, and Drugs for Neglected Diseases.

There are one hundred and thirty-eight US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Emodepside
TitleSponsorPhase
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and HookwormPublic Health Laboratory Ivo de CarneriPhase 2
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and HookwormJennifer KeiserPhase 2
Safety, Tolerability and PK of Multiple-ascending Doses of EmodepsideBayerPhase 1

See all Emodepside clinical trials

Clinical Trial Summary for Emodepside

Top disease conditions for Emodepside
Top clinical trial sponsors for Emodepside

See all Emodepside clinical trials

US Patents for Emodepside

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Emodepside ⤷  Try it Free Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Try it Free
Emodepside ⤷  Try it Free Method for formulating large diameter synthetic membrane vesicles Pacira Pharmaceuticals, Inc. (San Diego, CA) ⤷  Try it Free
Emodepside ⤷  Try it Free Anthelmintic compounds MERIAL INC. (Duluth, GA) ⤷  Try it Free
Emodepside ⤷  Try it Free Pyrazolopyridine sulfonamides as nematicides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Emodepside

Drugname Country Document Number Estimated Expiration Related US Patent
Emodepside Australia AU2015286634 2034-07-11 ⤷  Try it Free
Emodepside Brazil BR112017000398 2034-07-11 ⤷  Try it Free
Emodepside China CN106659720 2034-07-11 ⤷  Try it Free
Emodepside European Patent Office EP3177291 2034-07-11 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Moodys
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.